⌘K

Login Start Free

Home/Filings/4/0001453727-13-000019

4//SEC Filing

ACCELRYS, INC. 4

Accession 0001453727-13-000019

CIK 0001002388operating

View on SEC.gov Company Profile

Filed

Sep 24, 8:00 PM ET

Accepted

Sep 25, 6:30 PM ET

Size

4.7 KB

Accession

0001453727-13-000019

Insider Transaction Report

Form 4

Period: 2013-09-23

ACCELRYS, INC.ACCL

VP, Research and Development

Transactions

Sale
Common stock
2013-09-23$9.95/sh−15,000$149,289→ 0 total

Footnotes (1)

[F1]Pursuant to his 10b5-1 plan, Dr. Hahn disposed of common stock acquired through sale of Scitegic to Accelrys in 2004.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

ACCELRYS, INC.

CIK 0001002388

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001002388

Filing Metadata

Form type: 4
Filed: Sep 24, 8:00 PM ET
Accepted: Sep 25, 6:30 PM ET
Size: 4.7 KB

View on SEC.gov